Sodium nitrite-sodium thiosulfate combination therapy

Drug Profile

Sodium nitrite-sodium thiosulfate combination therapy

Alternative Names: NDC 60267-812-00; Nithiodote; Sodium thiosulfate-sodium nitrite

Latest Information Update: 11 Aug 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hope Pharmaceuticals
  • Class Antidotes; Nitrites; Nitrogen compounds; Sodium compounds; Thiosulfates; Vasodilators
  • Mechanism of Action Antioxidants; Cytochrome modulators; Haemoglobin modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Poisoning
  • New Molecular Entity No

Highest Development Phases

  • Marketed Poisoning

Most Recent Events

  • 08 Aug 2011 Launched for Acute cyanide poisoning in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top